Stock Events

Stock Events

NovelStem International 

$0.01
2
+$0+0% Friday 19:59

Statistics

Day High
0.01
Day Low
0.01
52W High
0.04
52W Low
0.01
Volume
20,000
Avg. Volume
10,873
Mkt Cap
468,810
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Mar 18
$0.45
Mar 18
$0.45
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

2NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-26,941.67%Profit Margin
Unprofitable
2011
2012
2013
2022
2023
2024
24,000Revenue
-6.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NSTM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stem
STEM
Mkt Cap164.53M
StemCells, Inc. focuses on cell-based therapeutic products which directly compete with NovelStem's offerings in regenerative medicine.
Biolife Solutions
BLFS
Mkt Cap1.34B
BioLife Solutions develops biopreservation media products for cells, competing in the cell therapy and regenerative medicine sector.
Mesoblast
MESO
Mkt Cap2.14B
Mesoblast Limited develops mesenchymal lineage adult stem cells to treat inflammatory ailments, competing in the same niche as NovelStem.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap6.74M
Brainstorm Cell Therapeutics develops autologous stem cell therapies for debilitating neurodegenerative diseases, a field also targeted by NovelStem.
Vericel
VCEL
Mkt Cap1.77B
Vericel Corporation produces autologous cell therapies for the treatment of patients with serious diseases and conditions, competing with NovelStem's products.
Fate Therapeutics
FATE
Mkt Cap155.7M
Fate Therapeutics is involved in the development of programmed cellular immunotherapies for cancer and immune disorders, areas also explored by NovelStem.

About

NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
Show more...
CEO
Mr. Jan H. Loeb
Country
US
ISIN
US67001V1098

Listings

OTC Link
US
NSTM

0 Comments

Share your thoughts

FAQ

What is NovelStem International stock price today?▼
The current price of NSTM is $0.01 USD — it has increased by +0% in the past 24 hours. Watch NovelStem International stock price performance more closely on the chart.
What is NovelStem International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovelStem International stocks are traded under the ticker NSTM.
What is NovelStem International market cap?▼
Today NovelStem International has the market capitalization of 468,810
What were NovelStem International earnings last quarter?▼
NSTM earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NovelStem International revenue for the last year?▼
NovelStem International revenue for the last year amounts to 24,000 USD.
What is NovelStem International net income for the last year?▼
NSTM net income for the last year is -6.47M USD.
Does NovelStem International pay dividends?▼
Yes, NSTM dividends are paid en. The last dividend per share was 0.45 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is NovelStem International located?▼
NovelStem International operates in the Health Care sector.
When did NovelStem International complete a stock split?▼
NovelStem International has not had any recent stock splits.
Where is NovelStem International headquartered?▼
NovelStem International is headquartered in Boca Raton, US.